Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China
· Delayed Price · Currency is CNY 7.51
+0.20 (2.74%)
Apr 30, 2026, 1:00 PM CST
SHE:002349 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 261.84 | 212.65 | 247.7 | 212.23 | 160.7 | Upgrade
|
| Depreciation & Amortization | 80.58 | 76.31 | 85.34 | 109.93 | 102.5 | Upgrade
|
| Other Amortization | - | 0.2 | - | 2.84 | 3.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.2 | 0.09 | 0.06 | 0.58 | Upgrade
|
| Asset Writedown & Restructuring Costs | 12.35 | 2.13 | 4.52 | 16.96 | 16.7 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.75 | -8.19 | -7.07 | -29.46 | -31.44 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 3.37 | 2.72 | 4.26 | 14.59 | Upgrade
|
| Other Operating Activities | -7.44 | 42.54 | 36.19 | 16.98 | 3.98 | Upgrade
|
| Change in Accounts Receivable | -13.2 | -11.17 | -40.56 | 125.18 | 9.28 | Upgrade
|
| Change in Inventory | -17.73 | 6.43 | 11.18 | -27.82 | -31.09 | Upgrade
|
| Change in Accounts Payable | 13.19 | -17.32 | -46.61 | -103.34 | 56.47 | Upgrade
|
| Change in Other Net Operating Assets | 17.69 | 4.44 | -5.05 | 29.53 | -4.15 | Upgrade
|
| Operating Cash Flow | 340.87 | 311.02 | 291.31 | 358.39 | 305.57 | Upgrade
|
| Operating Cash Flow Growth | 9.60% | 6.77% | -18.72% | 17.29% | -6.90% | Upgrade
|
| Capital Expenditures | -20.32 | -30.92 | -28.38 | -61.59 | -80.55 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.12 | 0.26 | 0.09 | 2.61 | Upgrade
|
| Divestitures | - | - | - | 71.41 | 0.41 | Upgrade
|
| Investment in Securities | -324.75 | -130.69 | -191.24 | 91.1 | 4.32 | Upgrade
|
| Other Investing Activities | -124.56 | 11.69 | 6.99 | 7.58 | 4.23 | Upgrade
|
| Investing Cash Flow | -469.59 | -105.81 | -212.37 | 108.59 | -68.97 | Upgrade
|
| Short-Term Debt Issued | - | 10 | 20.9 | 85.52 | 70.07 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 3.3 | - | Upgrade
|
| Total Debt Issued | - | 10 | 20.9 | 88.82 | 70.07 | Upgrade
|
| Short-Term Debt Repaid | - | -20.9 | -21 | -163.9 | -157.27 | Upgrade
|
| Long-Term Debt Repaid | -10 | -1.34 | -1.24 | -29.7 | -22.8 | Upgrade
|
| Total Debt Repaid | -10 | -22.24 | -22.24 | -193.6 | -180.07 | Upgrade
|
| Net Debt Issued (Repaid) | -10 | -12.24 | -1.34 | -104.77 | -110 | Upgrade
|
| Issuance of Common Stock | 56.71 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -84.99 | -75.55 | -65.98 | -54 | -44.5 | Upgrade
|
| Other Financing Activities | 4.57 | -20.23 | -26.84 | -23.27 | -21.71 | Upgrade
|
| Financing Cash Flow | -33.71 | -108.02 | -94.16 | -182.05 | -176.21 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.27 | 2.13 | 2 | 4.1 | -1.12 | Upgrade
|
| Net Cash Flow | -164.71 | 99.32 | -13.22 | 289.03 | 59.27 | Upgrade
|
| Free Cash Flow | 320.54 | 280.1 | 262.93 | 296.8 | 225.02 | Upgrade
|
| Free Cash Flow Growth | 14.44% | 6.53% | -11.41% | 31.90% | 7.28% | Upgrade
|
| Free Cash Flow Margin | 21.96% | 19.98% | 17.39% | 18.87% | 16.57% | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.34 | 0.32 | 0.36 | 0.28 | Upgrade
|
| Cash Income Tax Paid | - | 156.55 | 171.77 | 131.1 | 120.84 | Upgrade
|
| Levered Free Cash Flow | 304.17 | 186.18 | 132.98 | 198.73 | 69.94 | Upgrade
|
| Unlevered Free Cash Flow | 304.53 | 187.01 | 134.59 | 202.98 | 78.03 | Upgrade
|
| Change in Working Capital | 1.28 | -18.19 | -78.17 | 24.6 | 34.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.